Guest guest Posted August 3, 2004 Report Share Posted August 3, 2004 Aqui esta: http://www.boston.com/business/technology/biotechnology/articles/2004/08/02/unfo\ cused_elixir_seeks_new_life/ o http://snipurl.com/86ze >From: " glorydaze21 " <twood04@...> >Reply- > >Subject: [ ] post article >Date: Tue, 03 Aug 2004 02:32:51 -0000 > >Greetings... >There was an article on the front page of the boston globe's business & >innovation section today (aug. 2) regarding a company called Elixir >Pharmaceuticals (and another called Centagenetix, which recently merged >with Elixir -- both are based in Cambridge) that is attempting to figure >out why >CR does what it does in hopes of creating a pill that will do the same >thing. >Apparently, the reality of scarce financial resources is causing the >company to >focus less on the core research (i.e., yeast and worm genes) and more on >other pill ideas that could be brought to market -- and therefore reap >profits for >shareholders -- more quickly. It is an interesting article, worth searching >for on >the globe's website and reading for yourself. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.